A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Clinical trial NCT00401765 · COMPLETED

Trial details

NCT number: NCT00401765
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2005-09-01
Primary completion: 2009-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.